Subchronic Haloperidol Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic Patients In Vivo-Reference-Cited by-同舟云学术

Subchronic Haloperidol Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic Patients In Vivo

Published:2002-10-30 Issue:4 Volume:28 Page:787-794
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Gründer Gerhard,Vernaleken Ingo,Müller Matthias J,Davids Eugen,Heydari Nilufar,Buchholz Hans-Georg,Bartenstein Peter,Munk Ole L,Stoeter Peter,Wong Dean F,Gjedde Albert,Cumming Paul

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/1300103.pdf

Reference64 articles.

1. Amin F, Davidson M, Davis KL (1992). Homovanillic acid measurement in clinical research: a review of methodology. Schizophr Bull 18: 123–148.

2. Andreasen NC, Arndt S, Swayze II V, Cizadlo T, Flaum M, O'Leary D et al (1994). Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 266: 294–298.

3. Arciniegas D, Rojas DC, Teale P, Sheeder J, Sandberg E, Reite M (1999). The thalamus and the schizophrenia phenotype: failure to replicate reduced volume. Biol Psychiatry 45: 1329–1335.

4. Barnes TR (1989). A rating scale for drug-induced akathisia. Br J Psychiatry 154: 672–676.

5. Bouthenet ML, Martres MP, Sales N, Schwartz JC (1987). A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride. Neuroscience 20: 117–155.

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amphetamine-Induced Dopamine Release Predicts 1-Year Outcome in First-Episode Psychosis: A Naturalistic Observation;Schizophrenia Bulletin;2024-08-13

2. The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment;Translational Psychiatry;2023-05-31

3. Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal;Biomedicines;2023-03-14

4. The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings;European Neuropsychopharmacology;2023-03

5. Striatal dopamine synthesis capacity and neuromelanin in the substantia nigra: A multimodal imaging study in schizophrenia and healthy controls;Neuroscience Applied;2023